
We Want To Hear From As Many People As Possible, Says COVID-19 Inquiry Chair
With four days remaining until the close of public submissions, Grant Illingworth KC, Chair of the COVID-19 Inquiry, wants to reiterate how important it is that the Inquiry hears from as many people as possible about their COVID-19 experiences.
'Hearing from the public is a very important part of the work of the COVID-19 Inquiry,' Mr Illingworth says. 'By hearing about a wide range of experiences, we can understand the impact the pandemic and New Zealand's response to it had on New Zealanders, as well as what the public think should be done to address future pandemics.'
The Inquiry's public submissions portal has been open since 3 February 2025, and closes at midnight on 27 April 2025. Anyone who wants to make a submission can either fill in the on-line form at www.covid19inquiry.nz, or by calling 0800 500 306.
Resources for making a submission are available in English, te reo Māori, Samoan, Tongan, Hindi, Simplified Chinese, New Zealand Sign Language, Easy Read, Braille, Audio, and Large Print.
'We want to hear from individuals, communities, businesses, iwi, and others on how their lives were affected and changed during the pandemic. These experiences will help us provide careful, considered recommendations to the Government on how our country can be prepared to respond to future pandemics.'
The Inquiry is currently reviewing key decisions the New Zealand Government made in response to the pandemic between February 2021 and October 2022. A key decision is one made by the Government that had a significant impact on a large number of people or had a significant cost at a national or regional level (or both).
The Inquiry's focus is on three main areas:
Vaccines, including the use of mandates, the approval of vaccines, and vaccine safety
Lockdowns, especially the national lockdown in August and September 2021 and the Auckland/Northland extended lockdown late 2021.
Testing, tracing, and other public health tools.
When reviewing these decisions, the Inquiry will consider potential lessons on how best to balance people's health, social needs (including things like education and contact with friends and family) and economic impacts.
So far, the Inquiry has received more than 7300 submissions from the public.
'Thank you to everyone who has taken the time to make a submission to the Inquiry so far,' Mr Illingworth says. 'We are very grateful to everyone who has shared their experience, especially as many of these experiences are not easy to share.
'The COVID-19 pandemic was an incredibly difficult time, and many people are still feeling the effects of the pandemic and the response to it, whether those be physical, emotional, or financial.'
Vaccine mandates is a topic of significant focus for many submitters to date from across Aotearoa New Zealand. The use of lockdowns is also a frequently discussed topic, particularly among residents of the Auckland and Northland regions.
'We are pleased to have heard from people across all regions of Aotearoa New Zealand, as well as from a range of age groups and ethnicities,' Mr Illingworth says.
'Everyone experienced different impacts from the pandemic and the Government's response to it,' Mr Illingworth says.
'The broader the range of people we hear from, the better the picture we can build of Aotearoa New Zealand's pandemic experience to help us identify lessons that can be learned from the pandemic response.'
As part of its work, the Inquiry is also seeking evidence from a range of sources. Over the coming months, the Inquiry will be holding interviews with key decision makers and advisors, holding engagements with key communities impacted by the pandemic, and collecting information and evidence, including from Government departments. The Inquiry will also be holding public hearings later in 2025.
'The Inquiry's overall purpose is to ensure we learn the lessons from the pandemic response, and to make sure Aotearoa New Zealand is prepared for any future pandemics,' Mr Illingworth says. 'Our goal is to provide recommendations – that can be understood by all New Zealanders – to help build a strong response for the future.'
Submissions can be made to the Inquiry through our online portal www.covid19inquiry.nz or by calling 0800 500 306. Submissions close on 27 April 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Otago Daily Times
7 hours ago
- Otago Daily Times
Pharmac considers extension to free vaccination programme
By Victor Waters of RNZ Pharmac says it's exploring ways to extend a free meningoccocal B vaccine programme, with an estimated 100,000 eligible pre-schoolers still not protected. Meningitis prevention advocates have pressured health officials to continue the campaign, which is due to end on August 31. Pharmac pharmaceuticals director Geraldine MacGibbon said Pharmac funds the meningococcal B vaccine for all children under the age of one. "In March 2023, Pharmac funded a catch-up programme for children under the age of five to better protect young New Zealanders from meningococcal B. "We understand that people are keen to see the catch-up period extended and we are actively exploring options for this." "We will keep interested groups, including the Meningitis Foundation, informed about any updates," MacGibbon said. According to the Meningitis Foundation Aotearoa New Zealand, meningococcal bacteria can cause meningococcal meningitis - inflammation of the meninges, the membrane lining of the brain and spinal cord - and/or septicaemia (blood poisoning). Foundation chair Gerard Rushton said the meningococcal B vaccination programme was initiated after a submission the foundation made to Parliament and an application to Pharmac. He said more than 400,000 doses were given out in the first 12 months of the campaign. "We're calling on Health New Zealand and the government to actually continue this programme, because we know it works. We know it will save lives. "We know it's going to take pressure off the already-stretched health system. "What we're saying is this campaign has been very successful and it's been proven that people want it, but there's still 100,000 of our tamariki that haven't been protected, so we're calling them to keep this programme going. "We're really concerned that this large sector of our community are going to miss out. The vaccination rates for our young are still far too low, but we need them to extend this programme, because we need to protect those 100,000 of our children who are still unvaccinated." A Health New Zealand spokesperson said it was are "responsible for the implementation of the programme". "Pharmac funds the meningococcal B catch-up programme and set the timeframe from 1 March 2023 to 31 August 2025." A Health New Zealand spokesperson said, as of 9 June 2025, 84 percent of eligible children under 15 months had at least one dose of the meningococcal B vaccine. "Whānau can access the meningococcal B vaccines from a range of places, including general practice, hauora Māori and Pacific providers, with many Wellchild Tamariki Ora Services, including Whānau Āwhina Plunket, offering immunisations. "There are also more than 122 pharmacies now offering the vaccine for children aged from three years. "The meningococcal B vaccination is a part of the national immunisation schedule. "As a part of the Government's Health Target, we are focused on lifting childhood immunisation rates and we are making good progress towards this goal," said the spokesperson. Meningitis Foundation Aotearoa New Zealand chair Gerard Rushton said his organisation didn't see a reason for the catch-up programme to be discontinued. "Māori and Pasifika are 4-5 times more likely to catch meningitis than the European population, so they are a higher risk at the moment. We struggle to understand why there's a vaccination programme at the moment that actually discriminates against them. "The full vaccination programme was that the babies are free, there was a catch-up programme for 13-month to 5-year-olds, and that first-year students in boarding schools, halls of residence, barracks or prisons could get it free." "We feel that discriminates against the biggest at-risk group we've got, which is our Māori and Pasifika, because they're under-represented at halls of residence and boarding schools," he said.


NZ Herald
12 hours ago
- NZ Herald
US Health Secretary Robert F. Kennedy Jr appoints new vaccine advisory group
US Health Secretary Robert F. Kennedy Jr has appointed a new vaccine advisory group to replace the one he dismissed earlier in the week, including on the new panel a biochemist who warned against Covid jabs. Kennedy, US President Donald Trump's point man on health, who is an admitted vaccine


Scoop
13 hours ago
- Scoop
New And Improved Radiology Services For Auckland City Hospital
Press Release – New Zealand Government Minister of Health Health Minister Simeon Brown has today announced funding for the first stage of a major project to upgrade and expand interventional radiology services at Auckland City Hospital. 'This project will significantly improve access to radiology services for patients across Auckland and beyond,' Mr Brown says. 'A $41.2 million investment will fund the initial phase of the project – including construction of a fourth interventional neuroradiology operating theatre equipped with state-of-the-art imaging technology and enhanced support services. 'Investing in modern health infrastructure is a priority for this Government to ensure New Zealanders can access timely, high-quality care when they need it. 'The existing interventional radiology facility is outdated and no longer suitable for the advanced imaging equipment clinicians need. Redesigning the space will enable the use of modern technology and support more sophisticated models of care that meet the increasing complexity of patient needs over the coming decade.' The expansion, expected to be operational by early 2027, will significantly boost capacity for emergency stroke interventions and complex neuroradiology procedures – including specialist treatments for children from across the country. Stage 1 will also deliver: A replacement fluoroscopy room An interventional ultrasound room A new biplane imaging machine An expanded short-stay ward The funding will also support development of a second business case to fully complete a new, purpose-built interventional radiology suite – strengthening services not only for Auckland, but for patients nationwide who require advanced interventional care. 'This project will help reduce wait times for interventional radiology procedures, which play a critical role in diagnosing and treating life-threatening conditions and guiding decisions for further specialist care. 'Better access to interventional radiology means faster diagnoses, less invasive treatments, and improved outcomes for patients,' Mr Brown says.